• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested.

作者信息

Buring J E, Glynn R J, Hennekens C H

出版信息

JAMA. 1995;274(8):654-5.

PMID:7637148
Abstract
摘要

相似文献

1
Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested.
JAMA. 1995;274(8):654-5.
2
[Calcium channel blockers scare].
Harefuah. 1997 Feb 2;132(3):223-5.
3
A delayed answer to the calcium blocker question.对钙通道阻滞剂问题的延迟回答。
J Am Coll Cardiol. 1996 Feb;27(2):510-1. doi: 10.1016/0735-1097(95)00601-x.
4
Myocardial infarction associated with antihypertensive drug therapy.
JAMA. 1996 Feb 21;275(7):516; author reply 517. doi: 10.1001/jama.275.7.516.
5
Calcium channel blockers and myocardial infarction.
J Fam Pract. 1996 Jan;42(1):30-2.
6
[Calcium channel blockers and cardiovascular morbidity mortality].[钙通道阻滞剂与心血管发病率及死亡率]
An Med Interna. 1997 May;14(5):217-9.
7
The pressure's on. A hypertension drug taken by 28 million people is under scrutiny. What are the other options?
Time. 2000 Sep 11;156(11):126.
8
Calcium antagonists and cardiovascular events in patients with hypertension and diabetes.
Lancet. 1998 Jan 17;351(9097):216-7. doi: 10.1016/S0140-6736(05)78175-7.
9
[Calcium antagonists and their impact on risk of coronary disease].[钙拮抗剂及其对冠心病风险的影响]
Med Clin (Barc). 1996 Oct 26;107(14):533-4.
10
From the LSMS Committee on Chronic Diseases. Recent media reports of potential risks from calcium antagonists.
J La State Med Soc. 1995 Aug;147(8):343.

引用本文的文献

1
Barriers to and strategies for effective blood pressure control.有效控制血压的障碍与策略
Vasc Health Risk Manag. 2005;1(1):9-14. doi: 10.2147/vhrm.1.1.9.58940.
2
COX-2 inhibitors and the heart: are all coxibs the same?环氧化酶-2抑制剂与心脏：所有的环氧化酶-2选择性抑制剂都一样吗？
Postgrad Med J. 2006 Apr;82(966):242-5. doi: 10.1136/pgmj.2005.042234.
3
COX 2 inhibitors, traditional NSAIDs, and the heart.环氧化酶-2抑制剂、传统非甾体抗炎药与心脏
BMJ. 2005 Jun 11;330(7504):1342-3. doi: 10.1136/bmj.330.7504.1342.
4
Influence of physician specialty on adoption and relinquishment of calcium channel blockers and other treatments for myocardial infarction.医生专业对钙通道阻滞剂及其他心肌梗死治疗方法的采用和放弃的影响。
J Gen Intern Med. 2001 Jun;16(6):351-9. doi: 10.1046/j.1525-1497.2001.016006351.x.
5
The influence of national guidelines on antihypertensive prescribing patterns.国家指南对降压药物处方模式的影响。
Curr Hypertens Rep. 2000 Jun;2(3):247-52. doi: 10.1007/s11906-000-0007-1.
6
Role of a third generation calcium antagonist in the management of hypertension.第三代钙拮抗剂在高血压治疗中的作用。
Drugs. 1999;57 Suppl 1:1-10. doi: 10.2165/00003495-199957001-00001.
7
Verapamil use in patients with cardiovascular disease: an overview of randomized trials.维拉帕米在心血管疾病患者中的应用：随机试验综述
Clin Cardiol. 1998 Sep;21(9):633-41. doi: 10.1002/clc.4960210906.
8
General internal medicine update. Information clinicians and teachers need to know.普通内科最新进展。临床医生和教师需要了解的信息。
J Gen Intern Med. 1996 Oct;11(10):613-21. doi: 10.1007/BF02599029.
9
Calcium channel blocker debate: true lies?钙通道阻滞剂之争：是真相还是谎言？
Cardiovasc Drugs Ther. 1996 Sep;10(4):413-5. doi: 10.1007/BF00051105.
10
The statistical basis of public policy: a paradigm shift is overdue.公共政策的统计基础：范式转变刻不容缓。
BMJ. 1996 Sep 7;313(7057):603-7. doi: 10.1136/bmj.313.7057.603.